
Explore SLEEK, an efficient transgene knock-in technology for clinically relevant cell types. Learn about this CRISPR-based method for improved gene editing and its potential impact on cell-based medicines.

Explore strategies to minimize off-target edits in gene editing experiments. Learn best practices, considerations for different scenarios, and optimized workflows to enhance precision in genome manipulation.

Explore CRISPR/Cas gene editing technology's evolution, applications, and importance in research and clinical settings. Learn about choosing effective CRISPR reagents for successful gene editing experiments.

Explore strategies for developing cellular therapies through gene editing and learn to create and validate tumor models for clinical translation of therapeutic cells.

Explore microfluidic vortex shedding for efficient cell engineering. Learn about Hydropore's intracellular delivery platform for rapid and gentle nucleic acid and gene editing complex delivery to various cell types.

Explore cutting-edge base editing techniques for treating spinal muscular atrophy, focusing on SMN2 gene modification to restore SMN protein levels and potentially provide a long-lasting cure.

Explore advanced gene-editing technology, focusing on CRISPR-Cas9 variants and ribonucleoprotein complexes for therapeutic applications in challenging disease areas.

Explore automated tools for consistent, reliable, and efficient plasmid and protein purification, Western blotting, and cell isolation. Gain insights from industry expert Rouba Najjar.

Explore gene editing frontiers and genotypic confirmation's role in cellular physiology research, disease understanding, and treatment development. Gain insights into precision genome engineering techniques.

Explore non-viral genome targeting and pooled knockin screening for advancing cellular therapies in solid tumors. Learn about innovative methods for large-scale genetic engineering of human immune cells.

Explore the ethical implications of gene editing with bioethicist Alta Charo. Gain insights into the history, benefits, and concerns surrounding genetic technologies and their impact on society.

Dan Rather explores gene editing's potential and ethical implications with filmmaker Adam Bolt, discussing their documentary "Human Nature" and the far-reaching consequences of this groundbreaking technology.

Explore the revolutionary potential of gene editing with Walter Isaacson. Delve into CRISPR technology, its applications, ethical concerns, and impact on disease treatment, human enhancement, and global health challenges.

Explore CRISPR gene-editing technology's potential in healthcare, its ethical implications, and future prospects with Nobel laureate Dr. Jennifer Doudna and author Walter Isaacson.

Explore CRISPR's potential to revolutionize agriculture, addressing global food security challenges while navigating ethical concerns and scientific advancements in gene editing technology.

Explore the revolutionary CRISPR gene-editing technology, its applications in medicine and agriculture, and the ethical challenges it presents for the future of human evolution and disease prevention.

Explore the potential dangers of synthetic biology and gene editing, their implications for humanity, and strategies to mitigate risks in this thought-provoking talk by Rob Reid.

Geneticist Jennifer Doudna explains CRISPR-Cas9, a revolutionary gene-editing technology, its potential for treating genetic diseases, and the ethical considerations surrounding its use in human DNA modification.

Explore CRISPR gene editing technology, its applications, and IDT's Alt-R products through an overview of design tools, reagents, and a case study on CRISPR solutions.

Explore how venture capital investments shape the future of healthcare, from cutting-edge technologies to innovative approaches in behavioral health and underserved communities.

Explore the mechanisms of neoantigen generation and immune system recognition in cancer immunotherapy, covering antigen presentation, immune activation, and emerging therapeutic strategies.